Deputy Director Stemcell and Cancer Institute KALBE
Abstract
Covid-19 has been a global health emergency and not only induced an unprecedented economic crisis in almost every country, but has led to social and educational crises. With the fast spreading and mutation rate of this virus, human lifestyle has been changed to mitigate the infection of SARS-CoV-2. However, this virus is still able to infect vaccinated people, thus reducing their quality of life for those who have post covid syndrome.
In this case report, we report 3 case studies of Mesenchymal Stem Cell Secretome to reduce lung fibrosis post covid in humans. All patients who tested negative after being infected by SARS-CoV-2 have breathing difficulty and weakness as the symptoms of post covid syndrome, then intramuscular Mesenchymal Stem Cell Secretome injections were administered and patients were monitored closely to see it^s effectiveness. After 1 month from the last injection, all patients were able to breathe normally, shown by reduction of lung fibrosis.
